Citation 114365

SATO,T: KAWAMOTO,A: TAMURA,A: TATSUMI,Y: FUJI,T:. (1992). MECHANISM OF ANTIOXIDANT ACITON OF PUERARIA GLYCOSIDE (PG)-1 (AN ISOFLAVONOID) AND MANGIFERIN (A XANTHONOID).. 40(3)

Citation Details

Title	MECHANISM OF ANTIOXIDANT ACITON OF PUERARIA GLYCOSIDE (PG)-1 (AN ISOFLAVONOID) AND MANGIFERIN (A XANTHONOID).
Authors	SATO,T: KAWAMOTO,A: TAMURA,A: TATSUMI,Y: FUJI,T:
Year	1992
Volume	40
Issue	3

Summary

Year: 1992

Journal: Unknown

Organisms and Their Experiments (5)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOPYRAN-4-ONE,4(H)-1: (8-BETA-D-GLUCOPYRANOSYL-7-HYDROXY-3-(3-4-DIHYDROXY-PHENYL):	ACTIVE
2	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOPYRAN-4-ONE,4(H)-1: (8-BETA-D-GLUCOPYRANOSYL-7-HYDROXY-3-(3-4-DIHYDROXY-PHENYL):	ACTIVE
3	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOPYRAN-4-ONE,4(H)-1: (8-BETA-D-GLUCOPYRANOSYL-7-HYDROXY-3-(3-4-DIHYDROXY-PHENYL):	ACTIVE
4	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOPYRAN-4-ONE,4(H)-1: (8-BETA-D-GLUCOPYRANOSYL-7-HYDROXY-3-(3-4-DIHYDROXY-PHENYL):	ACTIVE
5	NADPH CYTOCHROME P450 REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOPYRAN-4-ONE,4(H)-1: (8-BETA-D-GLUCOPYRANOSYL-7-HYDROXY-3-(3-4-DIHYDROXY-PHENYL):	INACTIVE
6	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOPYRAN-4-ONE,4(H)-1: (8-BETA-D-GLUCOPYRANOSYL-7-HYDROXY-3-(3-4-DIHYDROXY-PHENYL):	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOPYRAN-4-ONE,4(H)-1: (8-BETA-D-GLUCOPYRANOSYL-7-HYDROXY-3-(4-HYDROXY-3-METHOXY-PHENYL):	INACTIVE
2	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BENZOPYRAN-4-ONE,4(H)-1: (8-BETA-D-GLUCOPYRANOSYL-7-HYDROXY-3-(4-HYDROXY-3-METHOXY-PHENYL):	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	MANGIFERIN	ACTIVE
2	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANGIFERIN	ACTIVE
3	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANGIFERIN	ACTIVE
4	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANGIFERIN	ACTIVE
5	NADPH CYTOCHROME P450 REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANGIFERIN	WEAK ACTIVITY
6	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANGIFERIN	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	DAIDZEIN	INACTIVE
2	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAIDZEIN	INACTIVE
3	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAIDZEIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	RADICAL SCAVENGING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	WOGONIN	INACTIVE
2	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WOGONIN	ACTIVE
3	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WOGONIN	ACTIVE
4	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WOGONIN	INACTIVE
5	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WOGONIN	INACTIVE
6	NADPH CYTOCHROME P450 REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	WOGONIN	ACTIVE

Show SPARQL Queries (1)